Acute T-cell activation is detectable in unstable angina

Circulation

Volumn 95, Issue 7, 1997, Pages 1806-1812

  Neri Serneri, Gian Gastone ^a   Prisco, Domenico ^a   Martini, Francesca ^a   Gori, Anna Maria ^a   Brunelli, Tamara ^a   Poggesi, Loredana ^a   Rostagno, Carlo ^a   Gensini, Gian Franco ^a   Abbate, Rosanna ^a  

^a Clin Medica Generale e Cardiologia   (Italy)

Author keywords

angina; coronary disease; immune system; interleukins; lymphocytes

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; TRANSFERRIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UNSTABLE ANGINA PECTORIS;

EID: 0342378103     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.7.1806     Document Type: Article

References (63)

1. Braunwald E. Unstable angina: a classification. Circulation. 1989;80:410-414.
2. Neri Serneri GG, Gensini GF, Poggesi L, Trotta F, Modesti PA, Boddi M, Ieri A, Margheri M, Casolo GC, Bini M, Rostagno C, Carnovali M, Abbate R. Effect of heparin, aspirin or alteplase in reduction of myocardial ischaemia in refractory unstable angina. Lancet. 1990;335:615-618.
3. Maseri A, Chierchia S, L'Abbate A. Pathogenetic mechanisms underlying the clinical events associated with atherosclerotic heart disease. Circulation. 1980;62(suppl V):V-3-V-13.
4. Neri Serneri GG, Gensini GF, Carnovali M, Prisco D, Rogasi PG, Casolo GC, Fazi A, Abbate R. Association between time of increased fibrinopeptide A levels in plasma and episodes of spontaneous angina: a controlled prospective study. Am Heart J. 1987;113:672-677.
5. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981;304:685-691.
6. Willerson JT, Golino P, Eidt J, Campbell WB, Buja M. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80:198-205.
7. van der Berg EK, Schmitz JM, Benedict CR, Malloy CR, Willerson JT, Dehmer GJ. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation. 1989;79:116-124.
8. Ambrose JA, Hjemdahl-Monsen CE. Angiographic morphology of unstable plaque. In: Rutherford JD, ed. Unstable Angina. New York, NY: Marcel Dekker; 1992:49-68.
9. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
10. Neri Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, Dabizzi P, Poggesi L, Modesti PA, Trotta F, Rostagno C, Boddi M, Gensini GF. A transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation. 1992;86:790-797.
11. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid, a protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
12. Jude B, Agraou B, McFadden EP, Susen S, Bauters C, Lepelley P, Vanhaesbroucke C, Devos P, Cosson A, Asseman P. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation. 1994;90:1662-1668.
13. 2 in unstable angina investigated through a dual antithromboxane inhibitor: importance of activated monocytes. Coron Artery Dis. 1994;5:137-145.
14. Altieri DC. Coagulation assembly on leukocytes in transmembrane signaling and cell adhesion. Blood. 1993;81:569-579.
15. Marcus AJ. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism. Blood. 1990;76:1903-1907.
16. Calvin RB, Johnson RA, Mihm MC, Dvorak HF. Role of clotting system in cell mediated immunity: fibrin deposition in delayed skin reactions in man. J Exp Med. 1973;138:686-698.
17. Edwards RL, Rickles FR. Delayed hypersensitivity in man: effects of systemic anticoagulation. Science. 1978;200:541-543.
18. Hardin JA, Cronlund M, Haber E, Block J. Activation of blood clotting in patients with systemic lupus erythematosus: relationship to disease activity. Am J Med. 1978;65:430-436.
19. van der Wall AC. Atherosclerotic lesions in humans: in situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 1989;61:166-170.
20. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-15.
21. Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin MD, Concannon CA, Cowan M, Edwards C, Fuster V, Goldman L, Green LA, Grines CL, Lytle BW, Mc Cauley KM, Mushlin AI, Rose GC, Smith EE, Swain JA, Topol EJ, Willerson JT. Diagnosing and managing unstable angina. Circulation. 1994;90:613-622.
22. American Heart Association. Committee Report: a reporting system on patients evaluated for coronary artery disease. Circulation. 1975; 51:5-7.
23. Buja LM, Willerson JT. Clinicopathologic correlates of acute ischemic heart disease syndromes. Am J Cardiol. 1981;47:343-356.
24. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation. 1994;89:503-505.
25. Flugelman MY, Virmani R, Correa R, Yu XZ, Farb A, Leon MB, Elami A, Fu YM, Casscells W, Epstein SE. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina: a clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation. 1993;88:2493-2500.
26. van der Wall AC, Becker AE, Van Der Loos AM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
27. Wood NC, Symons JA, Duff GW. Serum interleukin-2 receptors in rheumatoid arthritis: a prognostic indicator of disease activity? Autoimmunity. 1988;1:353-361.
28. Crabtree JE, Juby LD, Heatly RV, Lobo AJ, Bullimore DW, Axon ATR. Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity. Gut. 1990;31: 1033-1036.
29. Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM. Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut. 1993;34:658-664.
30. Semenzato G, Pizzolo G, Zambello R. The interleukin-2/interleukin-2 receptor system: structural, immunological, and clinical features. Int J Clin Lab Res. 1992;22:133-142.
31. Cotner T, Williams JM, Christenson L, Shapiro HM, Strom TB, Strominger J. Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. J Exp Med. 1983;157:461-472.
32. Poulton TA, Gallagher A, Potts RC, Swanson JB. Changes in activation markers and cell membrane receptors on human peripheral blood T-lymphocytes during cell cycle progression after PHA stimulation. Immunology. 1988;64:419-425.
33. Robbins PA, Maino VC, Warner NL, Brodsky FM. Activated T cells and monocytes have characteristic patterns of class II antigen expression. J Immunol. 1988;141:1281-1287.
34. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med. 1990;113:619-627.
35. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma: relationship to disease seventy and atopic status. Am Rev Respir Dis. 1990;141:970-977.
36. Emeson EE, Robertson AL. T lymphocytes in aortic and coronary intimas: their potential role in atherogenesis. Am J Pathol. 1988;130:369-376.
37. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis. Atherosclerosis. 1989;9:567-570.
38. Stemme S, Rymo L, Hansson GK. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest. 1991;65:654-660.
39. Blum A, Sclarovsky S, Shohat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:20-22.
40. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in 'active' coronary disease. Am J Cardiol. 1990;65:168-172.
41. Carry M, Korley V, Willerson JT, Weigelt L, Ford-Hutchinson AW, Tagari P. Increased leukotriene excretion in patients with cardiac ischemia: in vivo evidence for 5-lipoxygenase activation. Circulation. 1992;85:230-236.
42. Sato T. Increased subendothelial infiltration of the coronary arteries with monocytes-macrophages in patients with unstable angina. Atherosclerosis. 1987;68:191-197.
43. Arbustini E, Grasso M, Diegoli M, Pucci A, Bramerio M, Ardissino D, Angoli L, De Servi S, Bramucci E, Munini A, Minzioni G, Viganò M, Specchia G. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical and biochemical study. Am J Cardiol. 1991;68:36B-50B.
44. Moreno PR, Falk E, Palacios IS, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
45. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
46. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenesis. N Engl J Med. 1989;320:915-924.
47. Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb. 1992;12:461-467.
48. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, Fogelman AM. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest. 1991;87:2253-2257.
49. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ. Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 1993;91:2572-2579.
50. Arbustini E, De Servi S, Bramucci E, Porcu E, Costante AM, Grasso M, Diegoli M, Fasani R, Morbini P, Angoli L, Boscarini M, Repetto S, Danzi G, Niccoli L, Campolo L, Lucreziotti S, Specchia G. Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. Am J Cardiol. 1995;75:675-682.
51. Escaned J, van Suylen RJ, Mac Leod DC, Umans VAWM, De Jong M, Bosman FJ, De Feyter PJ, Serruys PW. Histologic characteristics of tissue excised during directional atherectomy in stable and unstable angina. Am J Cardiol. 1993;71:1442-1447.
52. Lablanche JM, Hamon M, McFadden EP, Bauters C, Quandalle P, Escudero X, Bertrand ME. Size and color of intracoronary thrombi in unstable coronary syndromes: relation of angioscopic findings to clinical presentation. J Am Coll Cardiol. 1994;(special issue)408A. Abstract.
53. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 1991;88:1121-1127.
54. Barath P, Fishbein MC, Cao J, Berenson J, Helfant R, Forrester S. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 1990;65:297-302.
55. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med. 1992;116:1292-1300.
56. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
57. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci. 1995;7489:501-507.
58. Alexander RW. The coronary ischemic syndromes: relationship to the biology of atherosclerosis. In: Schlant RC. Alexander RW, eds. Hurst's The Heart. New York, NY: McGraw-Hill; 1994:1021-1031.
59. Willerson JT, Yao SK, McNatt J, Benedict CR, Anderson HV, Golino P, Murphree SS, Buja LM. Frequency and severity of cyclic flow alterations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci U S A. 1991;88:10624-10628.
60. de Feyter PJ, Suryapranata H, Serruys PW, Beatt K, van Domburg R, van den Brand M, Tijssen JJ, Azar AJ, Hugenholtz PG. Coronary angioplasty for unstable angina: immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome. J Am Coll Cardiol. 1988;12:324-333.
61. Bauters C, Lablanche JM, Mc Fadden EP, Leroy F, Bertrand ME. Repeat percutaneous coronary angioplasty: clinical and angiographic follow-up in patients with stable and unstable angina pectoris. Eur Heart J. 1993;14:235-239.
62. Abdelmeguid AE, Ellis SG, Sapp SK, Simpfendorfer C, Franco I, Willow PL. Directional coronary atherectomy in unstable angina. J Am Coll Cardiol. 1994;24:46-54.
63. de Groote P, Bauters C, Mc Fadden EP, Lablanche JM, Leroy F, Bertrand ME. Local lesion-related factors and restenosis after coronary angioplasty: evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty. Circulation. 1995;91:968-972.